Related Experiment Video
Updated: Mar 20, 2026

10:28
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
16.5K
Addressing voice recording replications for tracking Parkinson's disease progression
Lizbeth Naranjo1, Carlos J Pérez2, Jacinto Martín2
1Department of Mathematics, University of Extremadura, Avda. de la Universidad s/n, 10003, Cáceres, Spain. lizbeth@unex.es.
Medical & Biological Engineering & Computing
|May 23, 2016
Summary
This study introduces a novel Bayesian linear regression model to track Parkinson's disease symptom severity using voice analysis. The method effectively handles within-subject variability in voice recordings over time.
Area of Science:
- Biomedical Engineering
- Computational Neuroscience
- Speech Science
Background:
- Tracking Parkinson's disease (PD) symptom severity using voice analysis is challenging due to within-subject variability in replicated voice recordings.
- Existing pattern recognition methods struggle with non-identical replicated features caused by technological imperfections and biological variations.
- The temporal aspect of symptom progression is crucial for accurate PD monitoring.
Purpose of the Study:
- To propose a novel Bayesian linear regression approach for analyzing voice recordings to track Parkinson's disease symptom severity.
- To address the challenge of within-subject variability in replicated voice measurements.
- To incorporate the temporal dynamics of symptom progression into the analysis.
Main Methods:
- Automatic extraction of voice features from multiple recordings of the same subjects.
- Development of a Bayesian linear regression model to handle replicated measurements and time-dependent features.
- Implementation of Gibbs sampling-based approaches to overcome computational difficulties.
- Introduction of a penalized regression version to select optimal predictors.
Main Results:
- The proposed Bayesian linear regression approach effectively handles within-subject variability in voice features.
- The model successfully incorporates the time factor for tracking symptom severity.
- The penalized version aids in identifying the most informative voice features for PD monitoring.
- Gibbs sampling provided a computationally feasible solution for the complex model.
Conclusions:
- A novel Bayesian linear regression method is presented for tracking Parkinson's disease symptom severity from voice recordings.
- The approach accounts for within-subject variability and temporal changes, offering a more robust analysis.
- This methodology provides a promising tool for objective and continuous monitoring of PD progression.
Keywords:
Bayesian regression modelsLatent variablesLongitudinal dataParkinson’s diseaseReplicated measurementsVariable selectionVoice featuresMore Related Videos
Related Concept Videos
Parkinson's Disease: Treatment
1.3K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.3K
Parkinson's Disease: Overview
2.3K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.3K
Alzheimer's Disease: Treatment
1.2K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.2K

